Conventional clinical trials are fraught with inefficient
patient management and data handling practices, which has prompted trial
sponsors to implement digital innovation and virtual technologies across
different aspects of drug development.
Roots Analysis is pleased to announce the publication of its recent
study, titled, “Virtual
Clinical Trial Service Providers Market, 2020-2050”
The report features an extensive study of the current
landscape of industry players that are offering various types of innovative
clinical research platforms / solutions to the pharmaceutical and life sciences
industries. Amongst other elements, the report features:
§
An overview of the current market landscape of companies
offering solutions for virtual clinical trials, featuring information on year
of establishment, geographical location, company size and types of services
offered (study start-up, patient enrollment, drug logistics, data collection
and analysis, and patient retention).
§
Brief profiles of companies offering solutions for virtual
clinical trials, featuring information on their year of establishment,
respective headquarters, company size, key executives, service / technology
portfolio, recent developments and an informed future outlook.
§
A case study on the initiatives of big pharma players
related to virtual clinical trials, offering insights on such clinical studies
that have been conducted / planned by the aforementioned players, along with
details on associated constraints and the future plans of players engaged in
this domain.
§
An analysis of the funding and investments made in the
domain, in the period between 2014 and 2020 (till November), including
seed financing, venture capital financing, debt financing, grants, capital
raised from IPOs and subsequent offerings, at various stages of development in
companies that are engaged in this field, based on several parameters, such as
number of funding instances, amount invested, type of funding, leading players
and investors, and geographical analysis.
§
An analysis of the partnerships and collaborations inked in
the domain, in the period between 2014 and 2020 (till November), based
on several parameters, such as year of partnership, type of partnership,
application mentioned in agreement, target therapeutic area mentioned in the
agreement, type of partner, most active players and geographical analysis.
§
A detailed study highlighting the key differences between
traditional and virtual CROs and an elaborate road map, presenting the
requirements for a traditional CRO to transition to a virtual CRO business
model.
§
A brief case study highlighting the impact of COVID-19
pandemic on virtual clinical trial service providers market.
§
A detailed analysis of completed, ongoing and planned
virtual clinical trials, based on multiple parameters, such as trial
registration year, trial phase, trial status, type of sponsor / collaborator,
target therapeutic area, trial design, top sponsor, geographical location of
trial and enrolled patient population.
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
§
Therapeutic Area
§
Cardiovascular Disorders
§
CNS Disorders
§
Infectious Disorders
§
Metabolic Disorders
§
Oncological Disorders
§
Respiratory Disorders
§
Other Disorders
§
Phase of Development
§
Phase I
§
Phase II
§
Phase III
§
Phase IV
§
Key Geographical Regions
§
North America
§
Europe
§
Asia-Pacific
§
Rest of the World
Key
companies covered in the report
§
Cambridge Cognition
§
Center Point Clinical
Services
§
eClinicalHealth
§
IQVIA
§
Mytrus (Medidata
Solutions)
§
PanAmerican Clinical
Research
§
Science 37
§
VirTrial
For
more information, please click on the following link:
https://www.rootsanalysis.com/reports/virtual-clinical-trial-service-provides-market.html
Other Recent Offerings
1. Patient
Recruitment and Retention Services Market (2nd Edition) by Therapeutic
Areas (Cardiovascular Diseases, Oncological Disorders, Infectious Diseases, CNS
Disorders, Respiratory Disorders, Hematological Disorders and Others), Patient
Recruitment Steps (Pre-screening and Screening), Trial Phases (Phase I, Phase
II, Phase III and Phase IV), and Key Geographies (North America, Europe,
Asia-Pacific, Latin America, MENA, and RoW) – Industry Trends and Global
Forecasts, 2021-2030
2. Digital
Solutions for Biomarkers Market by Content (Standalone Software Solutions
and Combination Offerings), Purpose (Diagnosis, Early Screening, Monitoring,
and Predictive Insights), Type of Biomarker (Cognitive, Idiosyncratic,
Physiological, Vocal, and Other Biomarkers), Therapeutic Area, Business Model,
and by Key Geographical Regions (North America, Europe, Asia-Pacific, Middle
East and North Africa, and Rest of the World): Industry Trends and Global
Forecasts, 2021-2030
3. Pharmaceutical
and Life Sciences Real World Evidence (2nd Edition), 2021-2030:
Distribution by Applications (Early Stage Research, Clinical Development,
Regulatory Approval, Pricing / Reimbursement, Post-Approval Studies), Real
World Data Sources (Medical Claims, Clinical Trials, Clinical Setting, Patient
Powered and Others), Key Therapeutic Areas, and Geography (North America,
Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of
the World)
About Roots Analysis
Roots Analysis is one of the fastest growing market
research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
